Harb G - Search Results

1

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C; AIDS Clinical Trials Group A5071 Study Team. Chung RT, et al. Among authors: harb g. N Engl J Med. 2004 Jul 29;351(5):451-9. doi: 10.1056/NEJMoa032653. N Engl J Med. 2004. PMID: 15282352 Free PMC article. Clinical Trial.

2

Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis C.

Perrillo R, Rothstein KD, Rubin R, Alam I, Imperial J, Harb G, Hu S, Klaskala W. Perrillo R, et al. Among authors: harb g. J Viral Hepat. 2004 Mar;11(2):157-65. doi: 10.1046/j.1365-2893.2003.00482.x. J Viral Hepat. 2004. PMID: 14996351 Clinical Trial.

3

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.

Hou J, Yin YK, Xu D, Tan D, Niu J, Zhou X, Wang Y, Zhu L, He Y, Ren H, Wan M, Chen C, Wu S, Chen Y, Xu J, Wang Q, Wei L, Chao G, Constance BF, Harb G, Brown NA, Jia J. Hou J, et al. Among authors: harb g. Hepatology. 2008 Feb;47(2):447-54. doi: 10.1002/hep.22075. Hepatology. 2008. PMID: 18080339 Clinical Trial.

4

Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial.

Chan HL, Heathcote EJ, Marcellin P, Lai CL, Cho M, Moon YM, Chao YC, Myers RP, Minuk GY, Jeffers L, Sievert W, Bzowej N, Harb G, Kaiser R, Qiao XJ, Brown NA; 018 Study Group. Chan HL, et al. Among authors: harb g. Ann Intern Med. 2007 Dec 4;147(11):745-54. doi: 10.7326/0003-4819-147-11-200712040-00183. Epub 2007 Oct 1. Ann Intern Med. 2007. PMID: 17909201 Free article. Clinical Trial.

5

A comparison of hepatitis C treatment and outcomes at academic, private and Veterans' Affairs treatment centres.

Jensen DM, Cotler SJ, Lam H, Harb G, Shillington A. Jensen DM, et al. Among authors: harb g. Aliment Pharmacol Ther. 2004 Jan 1;19(1):69-77. doi: 10.1046/j.1365-2036.2003.01817.x. Aliment Pharmacol Ther. 2004. PMID: 14687168 Free article.

6

Clinical utility of methicillin-resistant Staphylococcus aureus nasal PCR to streamline antimicrobial use in treatment of diabetic foot infection with or without osteomyelitis.

Harb G, Hopkins T, Yang L, Morneau K, Cadena-Zuluaga J, Walter E, Frei C. Harb G, et al. BMC Infect Dis. 2023 May 5;23(1):297. doi: 10.1186/s12879-023-08248-2. BMC Infect Dis. 2023. PMID: 37147579 Free PMC article.

7

Infections in Glucose-6-Phosphate Dehydrogenase G6PD-Deficient Patients; Predictors for Infection-Related Mortalities and Treatment Outcomes.

Alrahmany D, Omar AF, Hafez W, Albaloshi S, Harb G, Ghazi IM. Alrahmany D, et al. Among authors: harb g. Antibiotics (Basel). 2023 Mar 1;12(3):494. doi: 10.3390/antibiotics12030494. Antibiotics (Basel). 2023. PMID: 36978361 Free PMC article.

8

Stem cell sources and characterization in the development of cell-based products for treating retinal disease: An NEI Town Hall report.

Fortress AM, Miyagishima KJ, Reed AA, Temple S, Clegg DO, Tucker BA, Blenkinsop TA, Harb G, Greenwell TN, Ludwig TE, Bharti K. Fortress AM, et al. Among authors: harb g. Stem Cell Res Ther. 2023 Mar 29;14(1):53. doi: 10.1186/s13287-023-03282-y. Stem Cell Res Ther. 2023. PMID: 36978104 Free PMC article.

9

Quantifying Gram-Negative Resistance to Empiric Treatment After Repeat ExpoSure To AntimicRobial Therapy (RESTART).

Wibisono A, Harb G, Crotty M, Rahmanzadeh K, Alexander J, Hunter L, Dominguez E. Wibisono A, et al. Among authors: harb g. Open Forum Infect Dis. 2022 Dec 9;9(12):ofac659. doi: 10.1093/ofid/ofac659. eCollection 2022 Dec. Open Forum Infect Dis. 2022. PMID: 36582770 Free PMC article.

10

Acinetobacter baumannii Infection-Related Mortality in Hospitalized Patients: Risk Factors and Potential Targets for Clinical and Antimicrobial Stewardship Interventions.

Alrahmany D, Omar AF, Alreesi A, Harb G, Ghazi IM. Alrahmany D, et al. Among authors: harb g. Antibiotics (Basel). 2022 Aug 10;11(8):1086. doi: 10.3390/antibiotics11081086. Antibiotics (Basel). 2022. PMID: 36009955 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page